Production (Stage)
SBC Medical Group Holdings Incorporated
SBC
$4.55
$0.7118.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -13.65% | -28.76% | 12.28% | 29.51% | 27.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.65% | -28.76% | 12.28% | 29.51% | 27.72% |
| Cost of Revenue | -37.24% | -44.43% | -28.55% | 50.71% | 6.19% |
| Gross Profit | -4.52% | -21.89% | 29.08% | 23.48% | 38.59% |
| SG&A Expenses | -8.33% | -28.88% | 121.05% | -26.02% | -18.88% |
| Depreciation & Amortization | -52.37% | -- | -- | -- | -- |
| Other Operating Expenses | 145.25% | 82.45% | -37.20% | -6.80% | -47.89% |
| Total Operating Expenses | -23.79% | -35.76% | 44.01% | 1.50% | -4.67% |
| Operating Income | -1.06% | -17.56% | -30.91% | 75.27% | 120.82% |
| Income Before Tax | 15.62% | -74.29% | -37.79% | 62.49% | 121.61% |
| Income Tax Expenses | 17.84% | -105.23% | -21.05% | 25.16% | 44.31% |
| Earnings from Continuing Operations | 14.62% | -53.98% | -64.82% | 88.30% | 192.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 40.00% | -107.73% | -100.54% | -108.96% | 101.81% |
| Net Income | 14.63% | -54.41% | -66.10% | 73.25% | 212.50% |
| EBIT | -1.06% | -17.56% | -30.91% | 75.27% | 120.82% |
| EBITDA | -2.55% | -22.00% | -36.28% | 46.67% | 83.64% |
| EPS Basic | 4.57% | -58.24% | -66.40% | 73.25% | -- |
| Normalized Basic EPS | -11.46% | -18.56% | -36.85% | 50.07% | -- |
| EPS Diluted | 4.57% | -18.12% | -66.40% | 73.25% | -- |
| Normalized Diluted EPS | -11.46% | -18.56% | -36.85% | 50.07% | -- |
| Average Basic Shares Outstanding | 9.64% | 9.09% | 0.96% | 0.00% | -- |
| Average Diluted Shares Outstanding | 9.64% | 9.09% | 0.96% | 0.00% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |